5-(2-Aminoethyl)-2-oxazolidinones with central nervous system depressant and antiinflammatory activity.
D000374:Aggression / Q000187:drug effects; D000700:Analgesics / Q000138:chemical synthesis* / Q000494:pharmacology; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000138:chemical synthesis* / Q000627:therapeutic use; D001522:Behavior, Animal / Q000187:drug effects; D002351:Carrageenan; D002490:Central Nervous System / Q000187:drug effects*; D003441:Crowding; D003864:Depression, Chemical; D004487:Edema / Q000139:chemically induced / Q000188:drug therapy; D004569:Electroencephalography; D005021:Ethylamines / Q000138:chemical synthesis; D005071:Evoked Potentials / Q000187:drug effects; D005260:Female; D006801:Humans; D051379:Mice; D010080:Oxazoles / Q000138:chemical synthesis* / Q000494:pharmacology; D051381:Rats; D013329:Structure-Activity Relationship; D014149:Tranquilizing Agents / Q000138:chemical synthesis / Q000494:pharmacology
D000700:Analgesics; D000893:Anti-Inflammatory Agents; D005021:Ethylamines; D010080:Oxazoles; D014149:Tranquilizing Agents; D002351:Carrageenan